Physicians have spent years working to improve the care for women in menopause and perimenopause − from training providers to setting standards for hormone replacement therapy. Now they fear a lack of ...

Git isn't hard to learn, and when you combine Git and GitHub, you've just made the learning process significantly easier. This two-hour Git and GitHub video tutorial shows you how to get started with ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Since the beginning of the year, there have been multiple reports of ...

Multiple Chinese online platforms are openly selling tutorials on how to use AI to generate pornographic videos. For as little as 9.9 yuan ($1.4), users can purchase prompts to feed chatbots and ...

Demand for estrogen patches surged 26% after the FDA removed a black box warning on hormone therapy in 2025 Shutterstock Demand for estrogen patches surged 26% after the FDA removed a black box ...

Easing safety warnings, shift in sentiment toward HRT trigger sharp increases in use Patients report pharmacy-hopping and dose changes Manufacturers say complex production limit rapid scale-up April 9 ...

More women are seeking treatment for menopause and perimenopause, driving a shortage of estrogen patches, one of the most commonly used forms of hormone therapy. Manufacturers are struggling to keep ...

Doctors warn viral off-label use lacks evidence, with unknown long-term risks and possible systemic absorption Vaginal estrogen cream is prescribed to ease genital dryness, irritation and discomfort ...

From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Last summer, Angela Motter started experiencing some changes that began to interfere ...

Many women across the country are struggling to get their hands on estrogen patches after the FDA removed black box warning labels on many hormone therapy drugs. The removal was initially celebrated, ...

Estrogen patches, one of the most common forms of hormone therapy for women, are becoming harder to find, and some manufacturers say a recent action by Health and Human Services (HHS) Secretary Robert ...

Phase II Clinical Study of Adebrelimab and Bevacizumab Combined With Cisplatin/Carboplatin in Patients With Triple-Negative Breast Cancer With Brain Metastases (ABC Study) A deeper look reveals a ...